PLOD1 and hypogonadism: Undoubtedly, we question a possible pathogenetic role of hyperprolactinemia in the onset of hypogonadism in patients with COVID-19 because these patients also have significantly elevated LH levels, whereas hyperprolactinemia is known to be associated with low or inappropriately low LH levels.